文献速递帕金森病与运动障碍神经肌肉病神经免疫

表现为肌强直与肌束颤动的患者:抗IgLON5病的类固醇反应性表现

Patient With Rigidity and Fasciculations: Steroid-Responsive Presentation of Anti-IgLON5 Disease.
PubMed 文献 · Neurology · 2024-01-11

一例82岁男性,表现为持续2年的广泛肌束颤动、痛性痉挛、肢体僵硬、右下肢不自主运动、步态不稳和跌倒。神经生理检查示神经肌肉兴奋性增高,脑脊液tau蛋白升高(543 pg/mL;参考值<404)且脑脊液特异性寡克隆带阳性,血清和脑脊液抗IgLON5抗体阳性,携带HLA-DRB1*10:01等位基因。静脉甲泼尼龙(500 mg/d,共5天)后口服苯二氮䓬类药物,功能快速恢复,肢体僵硬和步态改善持续至6个月随访。

要点

  • 抗IgLON5病可表现为神经肌肉兴奋性增高与肌强直重叠的罕见表型。
  • 血清和脑脊液抗IgLON5抗体阳性支持诊断,本病与HLA-DRB1*10:01等位基因相关。
  • 静脉甲泼尼龙500 mg/d共5天继以口服苯二氮䓬类药物后功能快速恢复。

核心结论

  • 抗IgLON5病病程进展性且临床表现多样,本患者表现为神经肌肉兴奋性增高与肌强直的重叠症状。
  • 识别罕见表型很重要,因为及时识别和治疗可改善预后。

研究设计与样本

  • 单例病例报告,患者为82岁男性。

主要发现

  • 患者有持续2年的广泛肌束颤动、痛性痉挛和肢体僵硬,伴右下肢不自主运动、步态不稳和跌倒。
  • 神经生理检查示神经肌肉兴奋性增高体征。
  • 脑脊液tau蛋白浓度为543 pg/mL(参考值<404),脑脊液特异性寡克隆带阳性。
  • 血清和脑脊液抗IgLON5抗体阳性,携带HLA-DRB1*10:01等位基因。
  • 脑MRI、胸腹部CT、全身FDG-PET和视频多导睡眠图均无异常;未检出睡眠障碍、延髓症状、帕金森综合征或痴呆。

关键数值与推荐

  • 静脉甲泼尼龙500 mg/d共5天,继以口服苯二氮䓬类药物。
  • 治疗后肢体僵硬和步态改善,功能快速恢复,且改善持续至6个月随访。

临床怎么用

  • 本病例提示,对表现为神经肌肉兴奋性增高与肌强直重叠的患者,及时识别抗IgLON5病并给予免疫治疗可能改善预后(作者认为)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

An 82-year-old man presented with 2-year lasting widespread muscular fasciculations, cramps, and limb stiffness, with spontaneous movements in the right lower limb, unsteady gait (Video 1), and falls. Neurophysiologic studies disclosed signs of neuromuscular hyperexcitability. CSF analysis showed high tau protein concentration (543 pg/mL; reference values, <404) and unique-to-CSF oligoclonal bands. Serum and CSF anti-IgLON5 antibodies were positive (Figure 1). He carried the anti-IgLON5 disease-associated HLA-DRB1*10:01 allele.1 Brain MRI, thoracoabdominal CT, whole-body FDG-PET, and video-polysomnography were unremarkable. No sleep disturbances, bulbar symptoms, parkinsonism, or dementia were detected. Intravenous methylprednisolone (500 mg/d for 5 days), followed by oral benzodiazepines, prompted rapid functional recovery, with limb stiffness and gait improvement (Video 1), which persisted at 6-month follow-up. Anti-IgLON5 disease has progressive course and protean clinical presentations,2 representative, in our patient, for overlapping signs and symptoms of neuromuscular hyperexcitability and rigidity. Identification of rare phenotypes is important because prompt recognition and treatment can improve prognosis.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Bellucci M, Castellano C, Marinelli L, et al. Patient With Rigidity and Fasciculations: Steroid-Responsive Presentation of Anti-IgLON5 Disease. Neurology. 2024. PMID: 38207275. doi:10.1212/WNL.0000000000208110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。